×
About 4,482 results

ALLMedicine Bacterial Vaginosis Center

Research & Reviews  2,001 results

Vaginal probiotic adherence and acceptability in Rwandan women with high sexual risk pa...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247375
BMJ Open; Verwijs MC, Agaba S et. al.

May 21st, 2020 - To evaluate adherence and acceptability of intermittent vaginal probiotic or antibiotic use to prevent bacterial vaginosis (BV) recurrence. Repeated adherence and acceptability assessments using mixed methods within a pilot randomised controlled t...

Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis.
https://doi.org/10.1056/NEJMoa1915254
The New England Journal of Medicine; Cohen CR, Wierzbicki MR et. al.

May 13th, 2020 - Bacterial vaginosis affects 15 to 50% of women of reproductive age, and recurrence is common after treatment with an antibiotic agent. The high incidence of recurrence suggests the need for new treatments to prevent recurrent bacterial vaginosis. ...

Electrospun metronidazole-loaded nanofibers for vaginal drug delivery.
https://doi.org/10.1080/03639045.2020.1767125
Drug Development and Industrial Pharmacy; Tuğcu-Demiröz F, Saar S et. al.

May 12th, 2020 - Objective: To develop and characterize innovative vaginal dosage forms for the treatment of bacterial vaginosis (BV).Significance: This study is the first comparative evaluation of the metronidazole (MET)-loaded polyvinylpyrrolidone (PVP) nanofibe...

Extra-vaginal Bacterial Colonization and Risk for Incident Bacterial Vaginosis in a Pop...
https://doi.org/10.1093/infdis/jiaa233
The Journal of Infectious Diseases; Fredricks DN, Plantinga A et. al.

May 6th, 2020 - Bacterial vaginosis (BV) is a common cause of vaginal discharge and associated with vaginal acquisition of BV-associated bacteria (BVAB). We used quantitative PCR assays to determine if presence or concentrations of BVAB in the mouth, anus, vagina...

Five Percent Monolaurin Vaginal Gel for the Treatment of Bacterial Vaginosis: A Randomi...
https://doi.org/10.1097/LGT.0000000000000543
Journal of Lower Genital Tract Disease; Mancuso AC, Widdice LE et. al.

May 5th, 2020 - The aim of the study was to test the hypothesis that 5% monolaurin vaginal gel, a naturally occurring monoglyceride shown to have antimicrobial effects on vaginal pathogens without affecting Lactobacillus species, cures bacterial vaginosis (BV). T...

see more →

Guidelines  13 results

Screening for Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: US P...
https://doi.org/10.1001/jama.2020.2684
JAMA , Owens DK et. al.

Apr 7th, 2020 - Bacterial vaginosis is common and is caused by a disruption of the microbiological environment in the lower genital tract. In the US, reported prevalence of bacterial vaginosis among pregnant women ranges from 5.8% to 19.3% and is higher in some r...

No. 211-Screening and Management of Bacterial Vaginosis in Pregnancy.
https://doi.org/10.1016/j.jogc.2017.04.018
Journal of ObstEtrics and Gynaecology Canada : JOGC = Journal D'obstEtrique Et Gynecologie Du Canada : JOGC; Yudin MH, Money DM

Jul 21st, 2017 - To review the evidence and provide recommendations on screening for and management of bacterial vaginosis in pregnancy. The clinical practice options considered in formulating the guideline. Outcomes evaluated include antibiotic treatment efficacy...

Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasi...
https://doi.org/10.1016/S1701-2163(15)30316-9
Journal of ObstEtrics and Gynaecology Canada : JOGC = Journal D'obstEtrique Et Gynecologie Du Canada : JOGC; van Schalkwyk J, Yudin MH et. al.

May 23rd, 2015 - To review the evidence and provide recommendations on screening for and management of vulvovaginal candidiasis, trichomoniasis, and bacterial vaginosis. OUTCOMES evaluated include the efficacy of antibiotic treatment, cure rates for simple and com...

see more →

Drugs  71 results see all →

Clinicaltrials.gov  2,191 results

Vaginal probiotic adherence and acceptability in Rwandan women with high sexual risk pa...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247375
BMJ Open; Verwijs MC, Agaba S et. al.

May 21st, 2020 - To evaluate adherence and acceptability of intermittent vaginal probiotic or antibiotic use to prevent bacterial vaginosis (BV) recurrence. Repeated adherence and acceptability assessments using mixed methods within a pilot randomised controlled t...

Experimental Treatment Lowers Recurrence Risk of Bacterial Vaginosis in Phase 2 Test
https://www.medscape.com/viewarticle/930497

May 13th, 2020 - (Reuters Health) — Researchers say they have cut the recurrence rate of bacterial vaginosis by one third using an experimental treatment that injects a bacterium known as Lactin-V into the vagina to crowd out the noxious organisms that cause the c...

Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis.
https://doi.org/10.1056/NEJMoa1915254
The New England Journal of Medicine; Cohen CR, Wierzbicki MR et. al.

May 13th, 2020 - Bacterial vaginosis affects 15 to 50% of women of reproductive age, and recurrence is common after treatment with an antibiotic agent. The high incidence of recurrence suggests the need for new treatments to prevent recurrent bacterial vaginosis. ...

Electrospun metronidazole-loaded nanofibers for vaginal drug delivery.
https://doi.org/10.1080/03639045.2020.1767125
Drug Development and Industrial Pharmacy; Tuğcu-Demiröz F, Saar S et. al.

May 12th, 2020 - Objective: To develop and characterize innovative vaginal dosage forms for the treatment of bacterial vaginosis (BV).Significance: This study is the first comparative evaluation of the metronidazole (MET)-loaded polyvinylpyrrolidone (PVP) nanofibe...

Extra-vaginal Bacterial Colonization and Risk for Incident Bacterial Vaginosis in a Pop...
https://doi.org/10.1093/infdis/jiaa233
The Journal of Infectious Diseases; Fredricks DN, Plantinga A et. al.

May 6th, 2020 - Bacterial vaginosis (BV) is a common cause of vaginal discharge and associated with vaginal acquisition of BV-associated bacteria (BVAB). We used quantitative PCR assays to determine if presence or concentrations of BVAB in the mouth, anus, vagina...

see more →

News  189 results

Experimental Treatment Lowers Recurrence Risk of Bacterial Vaginosis in Phase 2 Test
https://www.medscape.com/viewarticle/930497

May 13th, 2020 - (Reuters Health) — Researchers say they have cut the recurrence rate of bacterial vaginosis by one third using an experimental treatment that injects a bacterium known as Lactin-V into the vagina to crowd out the noxious organisms that cause the c...

USPSTF Recommends Against Bacterial Vaginosis Screening for Most Pregnant Women
https://www.medscape.com/viewarticle/928326

Apr 8th, 2020 - NEW YORK (Reuters Health) - Based on updated evidence, the US Preventive Services Task Force (USPSTF) has reiterated its 2008 recommendation against screening for asymptomatic bacterial vaginosis in pregnant women who are not at increased risk for...

Vaginal artesunate quells CIN 2/3 lesions, clears HPV
https://www.mdedge.com/obgyn/article/219749/gynecologic-cancer/vaginal-artesunate-quells-cin-2/3-lesions-clears-hpv/page/0/1?channel=53

Mar 29th, 2020 - Safety and next steps The safety analysis showed that side effects were generally mild and well tolerated. There were 161 adverse events among 29 women for whom safety data were available.

Jury Still Out on BV Screening in Pregnancy for At-Risk Women
https://www.medpagetoday.com/obgyn/pregnancy/82631

Oct 8th, 2019 - Insufficient evidence exists to recommend routine screening for pregnant women at higher risk of preterm birth for bacterial vaginosis, the U.S. Preventive Services Task Force (USPSTF) said. There was not enough evidence to determine the benefits ...

see more →

Patient Education  17 results see all →